Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parinita Keshav Swarnkar

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|April 1, 2026
Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective StudyChristopher Stewart, Jaskaran Singh Bhangu, Parinita Keshav Swarnkar, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 1, 2026
Challenging the Treatment Threshold: Early Faricimab Prevents Vision Loss in nAMD - A Real-World Welsh ExperienceParinita Keshav Swarnkar, Jaskaran Singh Bhangu, Christopher Stewart, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Clinical Ophthalmology (Auckland, N.Z.)|April 1, 2026
Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective StudyChristopher Stewart, Jaskaran Singh Bhangu, Parinita Keshav Swarnkar, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 1, 2026
Challenging the Treatment Threshold: Early Faricimab Prevents Vision Loss in nAMD - A Real-World Welsh ExperienceParinita Keshav Swarnkar, Jaskaran Singh Bhangu, Christopher Stewart, et al.
Pageof 1